Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

Plans and Pricing

DrugPatentWatch Archives

You are currently viewing the 2006 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ALLEGRA-D 12 HOUR

« Back to Dashboard
Allegra-d 12 Hour is a drug marketed by Sanofi Aventis Us and is included in one NDA. There are six patents protecting this drug.

This drug has thirty-five patent family members in twenty-eight countries.

The generic ingredient in ALLEGRA-D 12 HOUR is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are sixteen drug master file entries for this compound. Five suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.

Summary for Tradename: ALLEGRA-D 12 HOUR

Patents:9
Applicants:1
NDAs:1
Formulation / Manufacturing:see details

Clinical Trials for: ALLEGRA-D 12 HOUR

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Sanofi Aventis Us
ALLEGRA-D 12 HOUR
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE; ORAL020786-001Dec 24, 1997RXYes6,037,353*PED<disabled><disabled>
Sanofi Aventis Us
ALLEGRA-D 12 HOUR
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE; ORAL020786-001Dec 24, 1997RXYes6,039,974<disabled><disabled>
Sanofi Aventis Us
ALLEGRA-D 12 HOUR
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE; ORAL020786-001Dec 24, 1997RXYes6,113,942*PED<disabled><disabled>
Sanofi Aventis Us
ALLEGRA-D 12 HOUR
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE; ORAL020786-001Dec 24, 1997RXYes5,578,610*PED<disabled><disabled>
Sanofi Aventis Us
ALLEGRA-D 12 HOUR
fexofenadine hydrochloride; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE; ORAL020786-001Dec 24, 1997RXYes6,187,791*PED<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: ALLEGRA-D 12 HOUR

Country Document Number Publication Date
Taiwan570812Jan 11, 2004
Turkey200000517Aug 21, 2000
Israel133420Apr 30, 2001
Slovakia283803Feb 03, 2004
Indonesia22891Dec 16, 1999
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc